Skip to main content

Joint Symposium JS.01 - Trends in Vaccinology

Joint Symposium with the International Union of Immunological Societies (IUIS)

Monday, September 3, 2018; 13:15-14:30; Room: Elicium

Chairpersons: Alberto Mantovani, Italy & Ursula Wiedermann, Austria

Bali Pulendran, United States of America
Systems Vaccinology: New chances for vaccines against communicable and non-communicable diseases

Franz X. Heinz, Austria
Novel vaccines against old foes: Dengue, Zika, Ebola & Co

Ed Lavelle, Ireland
New generation of adjuvants: each target group its own adjuvant?

Prize for Excellence in Vaccines Research and Development in Europe: announcement of the winner 2018 and ceremony (sponsored by Vaccines Europe).

 

 

Joint Symposium JS.02 - Systems Immunology for stratifying patients with autoimmune diseases

Joint Symposium with the European League Against Rheumatism (EULAR)

Monday, September 3, 2018; 13:15-14:30; Room: Auditorium

Chairpersons: Riita Lahesmaa, Finland & Timothy R.D. Radstake, The Netherlands

Timothy R.D. Radstake, The Netherlands
Molecular reclassification of Immune mediated inflammatory conditions as the road to personalised medicine

Andrea Cerutti, Spain
Forgotten antibodies of the gut mucosa: IgM and IgA2

Martha Alarcon-Riquelme, Spain
The Stratification of Lupus

 

 

Joint Symposium JS.03 - Antigen Presentation in Health and Disease

Joint Symposium with the American Association of Immunologists (AAI)

Monday, September 3, 2018; 13:15-14:30; Room: Forum

Chairpersons: Nilabh Shastri, United States of America & Anne Spurkland, Norway

Laura Santambrogio, United States of America
Lymph: composition, circulation and immunological role

Robert Binder, United States of America
Antigen processing and presentation in cancer immunosurveillance

Nilabh Shastri, United States of America
Generating peptide-MHC ligands for immune surveillance of foreign and self

 

 

Joint Symposium JS.04 - HLA in Transplantation and Autoimmunity

Joint Symposium with the European Federation for Immunogenetics (EFI)

Monday, September 3, 2018; 13:15-14:30; Room: E104-107

Chairpersons: Elissaveta Naumova, Bulgaria & Mieke Boots, The Netherlands

Frans Claas, The Netherlands
HLA and Solid Organ Transplantation

Katharina Fleischhauer, Germany
HLA in Haematopoietic Stem Cell Transplantation

Ludvig Sollid, Norway
HLA in Autoimmune Diseases

 

 

Joint Symposium JS.05 - Combinatorial approaches to develop targeted immunotherapeutics

Joint Symposium with the Russian-Georgian Society

Monday, September 3, 2018; 13:15-14:30; Room: E102

Chairpersons: Revaz Sepiashvili, Russia & Yvette van Kooyk, The Netherlands

Alexander Gabibov, Russia
Screening technologies for drug development.

Sergey Deyev, Russia
The hallmark of smart agents: Immunotargeting & controlled release

Annemiek van Spriel, Netherlands
Novel insights into membrane targeting of B cell lymphoma: lessons learned from tetraspanins

 

 

Joint Symposium JS.06 - From immunological insight to prevention of allergy

Joint Symposium with the European Academy of Allergy and Clinical Immunology (EAACI)

Tuesday, September 4, 2018; 13:15-14:30; Room: Elicium

Chairpersons: Edward Knol, The Netherlands & Jürgen Schwarze, United Kingdom

Liam O’Mahony, Ireland
Microbial induction of immune tolerance at mucosal surfaces

Milena Sokolowska, Switzerland
Immunoregulatory roles of lipid mediators in asthma and allergy

Oscar Palomares, Spain
Novel dendritic cell vaccines for the prevention and treatment of allergic diseases

 

 

Joint Symposium JS.07 - Subversion of phagocytosis in innate immunity: from efferocytosis to pathogen interaction

Joint Symposium with the Society for Leukocyte Biology (SLB)

Tuesday, September 4, 2018; 13:15-14:30; Room: Auditorium

Chairpersons: Pieter Leenen, The Netherlands & Véronique Witko-Sarsat, France

Tobias Dellenga, Germany
Neutrophils as targets for host-directed therapy against tuberculosis

Margarita Dominguez-Villar, United States of America
Differential signaling through TLR7 or TLR8 determines the phenotype of human monocytes during RNA viral infection

Justin Perry, United States of America
Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release

 

 

Joint Symposium JS.08 - Cytometry Building Bridges

Joint Symposium with the International Society for Advanced Cytometry (ISAC)

Tuesday, September 4, 2018; 13:15-14:30; Room: Forum

Chairpersons: Hyun-Dong Chang, Germany & Andrea Cossarizza, Italy

Andrea Cossarizza, Italy
Cytometry of aging of the immune system

Hyun-Dong Chang, Germany
Cytometry of intestinal microbiota

Tomas Kalina, Czech Republic
Standardizing cytometry of primary immunodeficiencies

 

 

Joint Symposium JS.09 - The gut microbiota and the IgA antibody production in health and disease

Joint Symposium with the Society for Mucosal Immunology (SMI)

Tuesday, September 4, 2018; 13:15-14:30; Room: E104-107

Chairpersons: Oliver Pabst, Germany & Jo Spencer, United Kingdom

Maria Rescigno, Italy
IgA, microbiota and cancer

Andrew Macpherson, Switzerland
Antibodies set boundaries limiting microbial metabolite penetration and the resultant mammalian host response

Nils Lycke, Sweden
The regulatory microenvironment in  Peyer's patches leading to synchronized gut IgA responses

 

 

Joint Symposium JS.10 - Innate host pathogen interactions

Joint Symposium with the Japanese Immunology Society (JIS)

Tuesday, September 4, 2018; 13:15-14:30; Room: G106-107

Chairpersons: Esther de Jong, The Netherlands & Shimon Sakaguchi, Japan

Sho Yamasaki, Japan
Protective role of Mincle in bacterial infection

Hisashi Arase, Japan
LILR family receptors in host pathogen interactions

Kazuyo Moro, Japan
ILC2 and type 2 immune diseases